The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
<h3>Objective</h3><p dir="ltr">This study examined the initial impact of a national BNT162b2 vaccine rollout on SARS-CoV-2 infections in Qatar.</p><h3>Methods</h3><p dir="ltr">All individuals who had completed ≥14 days of follow-up by 16...
Saved in:
| Main Author: | Ahmed Zaqout (9538566) (author) |
|---|---|
| Other Authors: | Joanne Daghfal (9538551) (author), Israa Alaqad (20414108) (author), Saleh A.N. Hussein (20414111) (author), Abdullah Aldushain (20414114) (author), Muna A. Almaslamani (9538548) (author), Mohammed Abukhattab (9538614) (author), Ali S. Omrani (9590116) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
by: Farah M. Shurrab (16324961)
Published: (2022) -
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
by: Zohaib Yousaf (9617058)
Published: (2022) -
Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
by: Mohammad Altermanini (16810755)
Published: (2023) -
Acute myocarditis following administration of BNT162b2 vaccine
by: Mhd Baraa Habib (11721774)
Published: (2021) -
Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over time
by: Hiam Chemaitelly (439114)
Published: (2025)